US Health Secretary Will Now Sign Off On New Rules Passed By The US Food & Drug Administration 22/09/2020 Grace Ren The United States Food and Drug Administration on Tuesday proposed a new rule regarding regulation of medical products that would be the first in the agency’s history to also require the signature of United States Health and Human Services (HHS) Secretary, before it can be formally adopted. As such it will likely be a test […] Continue reading -> Africa Lagging In COVID-19 Clinical Trials As Global Studies Cross 1000 Mark 18/09/2020 Maina Waruru Nairobi, Kenya – Africa is trailing the rest of the world in conducting clinical studies on COVID-19 vaccines and drugs. Less than 70 registered studies for drugs and vaccines are currently taking place in Africa, out of more than 1000 studies being conducted globally. Only 8 of 102 clinical vaccine trials were being conducted in […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> US Food And Drug Administration Commissioner Walks Back Claims On Plasma Treatment For Coronavirus 26/08/2020 Grace Ren The US Food and Drug Administration Commission Stephen Hahn on Monday apologized for overstating the effectiveness of convalescent plasma as a treatment for COVID-19, after the agency faced backlash for Hahn’s claims that the treatment could reduce mortality by as much as 35%, made during an announcement of the FDA emergency approval of the therapy […] Continue reading -> Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Africa Lagging In COVID-19 Clinical Trials As Global Studies Cross 1000 Mark 18/09/2020 Maina Waruru Nairobi, Kenya – Africa is trailing the rest of the world in conducting clinical studies on COVID-19 vaccines and drugs. Less than 70 registered studies for drugs and vaccines are currently taking place in Africa, out of more than 1000 studies being conducted globally. Only 8 of 102 clinical vaccine trials were being conducted in […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> US Food And Drug Administration Commissioner Walks Back Claims On Plasma Treatment For Coronavirus 26/08/2020 Grace Ren The US Food and Drug Administration Commission Stephen Hahn on Monday apologized for overstating the effectiveness of convalescent plasma as a treatment for COVID-19, after the agency faced backlash for Hahn’s claims that the treatment could reduce mortality by as much as 35%, made during an announcement of the FDA emergency approval of the therapy […] Continue reading -> Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> US Food And Drug Administration Commissioner Walks Back Claims On Plasma Treatment For Coronavirus 26/08/2020 Grace Ren The US Food and Drug Administration Commission Stephen Hahn on Monday apologized for overstating the effectiveness of convalescent plasma as a treatment for COVID-19, after the agency faced backlash for Hahn’s claims that the treatment could reduce mortality by as much as 35%, made during an announcement of the FDA emergency approval of the therapy […] Continue reading -> Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> US Food And Drug Administration Commissioner Walks Back Claims On Plasma Treatment For Coronavirus 26/08/2020 Grace Ren The US Food and Drug Administration Commission Stephen Hahn on Monday apologized for overstating the effectiveness of convalescent plasma as a treatment for COVID-19, after the agency faced backlash for Hahn’s claims that the treatment could reduce mortality by as much as 35%, made during an announcement of the FDA emergency approval of the therapy […] Continue reading -> Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Food And Drug Administration Commissioner Walks Back Claims On Plasma Treatment For Coronavirus 26/08/2020 Grace Ren The US Food and Drug Administration Commission Stephen Hahn on Monday apologized for overstating the effectiveness of convalescent plasma as a treatment for COVID-19, after the agency faced backlash for Hahn’s claims that the treatment could reduce mortality by as much as 35%, made during an announcement of the FDA emergency approval of the therapy […] Continue reading -> Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> Posts navigation Older posts